
January 9, 2026/
Mesoblast lifts Ryoncil sales 60% as new US$125m facility strengthens balance sheet Mesoblast (ASX:MSB; Nasdaq:MESO) has reported a sharp acceleration…

Mesoblast lifts Ryoncil sales 60% as new US$125m facility strengthens balance sheet Mesoblast (ASX:MSB; Nasdaq:MESO) has reported a sharp acceleration…

US defence stocks have commenced 2026 with robust performance, continuing the strong momentum from the previous year. Escalating geopolitical tensions…

The US trade deficit experienced a significant contraction in October, according to data released by the Commerce Department’s Bureau of…

A recent survey by Goldman Sachs indicates that geopolitical factors are contributing to a bearish outlook on oil among institutional…
resources sector up 0.3% | futures dip during US presidential